Navigation Links
Anadys Pharmaceuticals to Present at the ROTH OC Growth Stock Conference
Date:3/9/2010

The corporate presentation will be simultaneously webcast and can be accessed on the Investor Relations page of the Company's website at www.anadyspharma.com.  Listeners are encouraged to visit the website approximately five minutes prior to the corporate presentation to download or install any necessary software.  A replay of the presentation will be available approximately one hour after the live webcast concludes and will be available through March 30, 2010.

About Anadys

Anadys Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to improving patient care by developing novel medicines for the treatment of hepatitis C.  The Company believes hepatitis C represents a large unmet medical need in which meaningful improvements in treatment outcomes may be attainable with the introduction of new medicines.  The Company is developing ANA598, a non-nucleoside polymerase inhibitor for the treatment of hepatitis C.  The Company has also investigated the potential of ANA773, an oral, small-molecule inducer of endogenous interferons that acts via the Toll-like receptor 7, or TLR7, pathway in hepatitis C.


'/>"/>
SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
2. Anadys Pharmaceuticals Announces Positive Results for ANA598 in Animal Model of Chronic Hepatitis C Virus Infection
3. Anadys Pharmaceuticals Presents Data on ANA598, a Non-Nucleoside Inhibitor of the HCV Polymerase, at the 21st International Conference on Antiviral Research
4. Anadys Pharmaceuticals Initiates Phase I Clinical Trial of ANA598
5. Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV
6. Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients
7. Anadys Pharmaceuticals to Present at the JMP Securities Healthcare Focus Conference
8. Anadys Pharmaceuticals Announces Single Dose Safety and Pharmacokinetics Results for ANA598 in Healthy Volunteers
9. Anadys Pharmaceuticals Commences Dosing in Phase II Study of ANA598
10. Anadys Pharmaceuticals to Present at Two Upcoming Investor Conferences
11. Anadys Pharmaceuticals to Present at the Oppenheimer Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... Sept. 3, 2015 Nevro Corp. (NYSE: ... providing innovative evidence-based solutions for the treatment of chronic ... at the Morgan Stanley Global Healthcare Conference on Thursday, ... Nevro management is scheduled to present at 11:45 ... live audio webcast, accessible in the "Investors" section of ...
(Date:9/3/2015)... Research and Markets ( http://www.researchandmarkets.com/research/twqfk6/global_medical ) has announced the ... - By Packaging type, Regions and Vendors - Market ... their offering. The growth of Medical ... use industry, i.e., Medical devices industry. More innovations are ... as to be tamper evident, and child-resistant. The industry ...
(Date:9/3/2015)... Sep. 03, 2015 Research ... of the "Investigation Report on China,s Raloxifene Market, ... to the statistics, over 200 million people suffer from ... above in China , 50% have ... 30%-50% among women aged 60 and above. Raloxifene ...
Breaking Medicine Technology:Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 2Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 3Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 4Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 5Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 6Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 7Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 8Investigation Report on China's Raloxifene Market, 2015-2019 2
... Feb. 15, 2011 Baxano, Inc. ( w w ... om ) today announced the addition of George A. Harter, ... Officer, Mr. Harter will be responsible for Finance, Administration and Human ... for Acclarent, Inc. from 2005 to 2011, through its acquisition by ...
... 2011 Takeda Pharmaceuticals International, Inc., a wholly-owned ... that its Pharmaceutical Development Division has entered into ... ) and Quintiles, two of the world,s largest ... of the agreements, Covance and Quintiles will work ...
Cached Medicine Technology:Baxano, Inc. Names George A. Harter, Jr. as Chief Financial Officer 2Takeda Enters Into Global Strategic Partnerships With Covance and Quintiles 2
(Date:9/4/2015)... ... September 04, 2015 , ... ... assistance company today announced that it has entered into a multi-year agreement with ... an agreement to bridge the link between American healthcare, Jamaican healthcare and Health ...
(Date:9/3/2015)... , ... September 03, 2015 , ... Allied Anesthesia is ... innovative medicine is the norm not the exception. , St. Jude was recently named ... Heart Association/American Stroke Association, making it one of only 10 hospitals in the state ...
(Date:9/3/2015)... , ... September 03, 2015 , ... ... academic partner for the Academy of Integrative Health & Medicine (AIHM) Interprofessional Fellowship ... direction of Tieraona Low Dog, MD, an internationally renowned educator, physician and thought ...
(Date:9/3/2015)... ... September 03, 2015 , ... Topical BioMedics, Inc., hosted Amsterdam ... his six-month, 10,000 mile journey from Santiago, Chile to Times Square and then ... “Connecting Las Americas” project—Max crossed six countries in 168 days on his 39-year-old ...
(Date:9/3/2015)... ... 2015 , ... Real Time Pain Relief (RTPR), makers of the ... Mason has signed an official endorsement deal with the company. Originally from New South ... first bull at 15. He is an Australian bull riding champion, following in his ...
Breaking Medicine News(10 mins):Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 2Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 3Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 4Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 5Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 6Health News:Allied Anesthesia Physicians Announce Partnership with St. Jude 2Health News:Allied Anesthesia Physicians Announce Partnership with St. Jude 3Health News:Oregon Collaborative for Integrative Medicine Partners with AIHM on First Interprofessional Fellowship 2Health News:Oregon Collaborative for Integrative Medicine Partners with AIHM on First Interprofessional Fellowship 3Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 2Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 3Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 4Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 5Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 6Health News:Real Time Pain Relief Sponsors the Talented PBR Bull Rider from Down Under - David Mason 2Health News:Real Time Pain Relief Sponsors the Talented PBR Bull Rider from Down Under - David Mason 3
... health minister Andy Kerr has ordered the closure of two ... to close the hospitals in the border as part of ... of the 80-year-old nine-bed Queen Margaret Hospital in Jedburgh and ... towns worked hard to save the community hospitals. The Jedburgh ...
... found that older people do not respond much over negative ... softens over a period of time. They analysed about 242 ... brain imaging techniques. Emotional stability was found to improve even ... comparatively less neurotic than teenagers. The study results were published ...
... On being asked how NHS could avoid system paralysis:,Sir Ian: "There ... to take is challenging - probably //among the most challenging in ... the excellent results that we published in our annual report ... ... ,"I think the picture you paint is really demanding - ...
... in south-east countries - Waterford Regional Hospital and Wexford General ... Health authorities //. ,So patients in those ... blood results. People whom visited that hospital between the period ... the disease. , ,People whom numbered around 1,000 ...
... for treatment of breast cancer is being misused by some ... , According to a BBC report , bodybuilders , who resort ... bodyweight, are abusing anti- cancer ... unpleasant side-effect of the steroids. Although derived from testosterone, ...
... industry is set to get a further boost with ... of medicare facilities overseas//. ,Global Medicare, a healthcare ... firm, have signed an agreement to endorse super-specialty medical ... the Middle East. ,"Initially we will ...
Cached Medicine News:Health News:NHS acting chief’s intervie 2Health News:Plan to Promote the Medicare Facilities of India to Abroad 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: